Cardiff Oncology announces CEO Erlander, CFO Levine have stepped down

Cardiff Oncology (CRDF) announced a leadership transition. Mani Mohindru, PhD, a member of Cardiff Oncology’s Board of Directors since 2021 and a seasoned biotech executive, has been appointed interim Chief Executive Officer, effective immediately. Mark Erlander, PhD, Chief Executive Officer, and James Levine, Chief Financial Officer, have stepped down from their respective roles. As part of this transition, Brigitte Lindsay has been promoted to the role of Chief Accounting Officer. She has been with the Company for more than 14 years and was most recently the Senior Vice President of Finance.